Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath (NYSE: PATH) defied critics in ...

UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental Portfolio ...

However, Palantir's huge gains have left the stock at a huge valuation; it's trading at a forward price-to-sales (P/S) ...

Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...

Revenue of $411 million increased 16 percent year-over-year ARR of $1.782 billion increased 11 percent year-over-year GAAP operating income of $13 million and non-GAAP operating income of $88 million ...

UiPath aims to lead the RPA market by integrating advanced AI solutions, differentiating itself from competitors like Automation Anywhere and Blue Prism. Strategic partnerships with tech giants like ...

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced that Ashim Gupta, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the 28th ...

UiPath stock jumped after news it will join the S&P MidCap 400, a move that could reshape near-term trading dynamics and investor attention.

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the ...